Nice, Alpes-maritimes, FRANCE - 19 Oct `22Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients

 

Official Title: Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients as Compared to Controls

Experimental: Vitiligo Group.  The subjects will be selected from among those presenting for the consultation or hospitalization of the Dermatology department of the CHU de Nice. All necessary information will be given to the subjects and a briefing note will be given to them. A reflection period will be left for the subjects to sign the informed consent, and if necessary, another appointment will be scheduled for the inclusion visit. If the subject consents and they meet all the criteria a 20 ml blood sample will be taken.


Contact: Passeron Thierry, PhD    +3349204688    passeron.t@chu-nice.fr  

Actual Study Start Date: October 19, 2022
Estimated Study Completion Date: October 1, 2023

https://beta.clinicaltrials.gov/study/NCT05525741

 

FAQOther Questions

  • What causes vitiligo?

    Surprisingly, the causes of vitiligo are yet to be precisely established. Researchers know the cause is pre-wired in your genes, just waiting for a bad luck moment. In about hal...

  • Which diseases most commonly accompany vitiligo?

    According to a 10-year study, vitiligo patients have a statistically significant higher prevalence of other autoimmune conditions and dermatological disorders: hypothyroidism...

  • Isn't it just a cosmetic disorder?

    Contrary to popular belief, vitiligo is not a cosmetic disorder but a systemic disease affecting the largest body organ and other vital systems, with multiple comorbidities. Fo...